Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.

Luis Gabriel Parra-Lara Juan José Martinez-Arboleda Daniel Francisco Isaza-Pierotti Fernando Rosso

Int J Antimicrob Agents

Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia; Infectious Diseases Service, Department of Internal Medicine, Fundación Valle del Lili, Cali, Colombia; Centro de Investigaciones Clínicas (CIC), Fundación Valle del Lili, Cali, Colombia.

Published: January 2021

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779262	PMC
http://dx.doi.org/10.1016/j.ijantimicag.2020.106172	DOI Listing

Publication Analysis

Top Keywords

estimation hydroxychloroquine

hydroxychloroquine covid-19

covid-19 secondary

secondary analysis

analysis open

open label

label non-randomized

non-randomized clinical

clinical trial

estimation

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!